K. Ramakrishnan Bhaskar

Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.

H. Friess, A. Kolb, D. Schuppan, 2008, Journal of hepatology.